ISSN: 2517-7370
Cancer is generally referred to as a disease that involves abnormal growth of cells that have the potential to spread in different parts of the body. The disease may be curable if detected in early stages. It is most prevalent disease ...
Explore the journal aims, scope and subject coverage before submission.
View editorial leadership and board information for this journal.
Browse current research articles and article updates from this journal.
Open Access publishing information is available for authors and readers.
Dr. Jen obtained her Ph.D. from University of California, San Francisco and completed her postdoctoral training at the Johns Hopkins University, School of Medicine. Dr. Jen joined the faculty at Johns Hopkins University in 1996 and then a principal investigator at NCI prior to joining the Mayo Clinic in 2008 where she served as the Director of the Mayo Gene Expression Analysis Core. Since 2015, Dr. Jen became the Co-Director for the Genome Analysis Core, Medical Genome Facility at the Center for Individualized Medicine where she leads the development and implementation of whole transcriptase sequencing technologies for research and clinical applications. Dr. Jen is an associate professor at the Department of Laboratory Medicine and Pathology and an expert in the molecular genetics of non-small cell lung cancer. Her current research focuses on using next-generation sequencing (NGS) and liquid biopsy approaches to identify genetic markers for optimized treatment stratification and disease monitoring in cancer.
Dr. Jen has co-authored many peer-reviewed publications and is an inventor to five published patents. She is an Associate Editor for Clinical Cancer Research and has served on study sessions for NIH and the American Cancer Society. Dr. Jen’s research has been funded by grants from the National Cancer Institute, National Foundation for Cancer Research, and the Mayo Clinic – University of Minnesota Partnership.
Discover peer-reviewed open access journals across diverse disciplines.
